Anchyra Partners’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
Anchyra Partners's MRK Position: Q2 2026 in Review
Anchyra Partners increased its Merck (MRK) stake by 5.8% in Q2 2026, buying an estimated $62.6K and bringing the position to 9,746 shares worth $1.25M. The position accounts for 0.3% of the portfolio, ranked #66.
Anchyra Partners first reported a position in MRK in Q4 2025 and has held it in 3 quarters since. 2,532 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Anchyra Partners held 9,746 shares of Merck worth $1.25M as of Q2 2026.
- Anchyra Partners bought 535 Merck shares in Q2 2026, an estimated $62.6K.
- Merck made up 0.3% of Anchyra Partners's portfolio in Q2 2026, its #66 holding.
- Anchyra Partners first reported a position in Merck in Q4 2025 and has held it in 3 quarters since.
- 2,532 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Anchyra Partners's 13F filing for Q2 2026, filed 23 Jul 2026.